National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
January 27, 2009 • Volume 6 / Number 2


ATCG's with silhouettes of people of varying heights

Study Forecasts Savings for Marker-based Colorectal Cancer Treatment

Using the anti-EGFR therapy cetuximab (Erbitux) to treat patients with metastatic colorectal cancer who have the normal form of the KRAS gene—and not the mutant form—would save more than $600 million annually, according to study results presented January 14 at the Gastrointestinal Cancers Symposium in San Francisco. Read more > >


Director's Update: Prelude to a New Chapter in the National Cancer Program

One week ago today the country inaugurated Barack Obama as our new president, an occasion accompanied by the excitement associated with such a historic election. There are great expectations that the new president will make significant changes—changes that will touch nearly every aspect of our daily lives, patient care and cancer research included. As a citizen and as NCI director, I share those expectations, the anticipation, and excitement of hope. The hope for an adjustment to our country's compass toward the renewed investment in science, in the creation of new knowledge, and in the education of our talented young people. Read more > >

A Conversation With...Dr. Richard Troiano

An NCI epidemiologist discusses the goals and implications of the 2008 Physical Activity Guidelines for Americans. Read more > >

In Depth


  • HHS Update

    • Top Department Heads Step Down
  • Notes

    • Gillanders Named an EGRP Branch Chief
    • NCI Symposium Addresses Impact of Biospecimens on Cancer Research

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at

Next Section >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health